GLP-1 analogs are more beneficial for type 2 diabetes

04/11/2012 | Medscape (free registration)

Biphasic insulin, basal insulin and glucagon-like peptide 1 analogs control blood glucose levels in people with type 2 diabetes, but GLP-1 analogs also encourage weight loss without raising the risk of hypoglycemia, a meta-analysis found. The results were published in Diabetes, Obesity and Metabolism.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN